Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients.
Shea TC, Walko C, Chung Y, Ivanova A, Sheets J, Rao K, Gabriel D, Comeau T, Wood W, Coghill J, Armistead P, Sarantopoulos S, Serody J. Shea TC, et al. Among authors: ivanova a. Biol Blood Marrow Transplant. 2015 Dec;21(12):2129-2135. doi: 10.1016/j.bbmt.2015.07.016. Epub 2015 Jul 22. Biol Blood Marrow Transplant. 2015. PMID: 26210442 Free PMC article. Clinical Trial.
Alternative donor hematopoietic stem cell transplantation for sickle cell disease.
Gilman AL, Eckrich MJ, Epstein S, Barnhart C, Cannon M, Fukes T, Hyland M, Shah K, Grochowski D, Champion E, Ivanova A. Gilman AL, et al. Among authors: ivanova a. Blood Adv. 2017 Jun 28;1(16):1215-1223. doi: 10.1182/bloodadvances.2017005462. eCollection 2017 Jul 11. Blood Adv. 2017. PMID: 29296761 Free PMC article.
Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation.
Davis JM, Ivanova A, Chung Y, Shaw JR, Rao KV, Ptachcinski JR, Sharf AA, Serody JS, Armistead PM, Wood WA, Coghill JM, Jamieson KJ, Vincent BG, Riches ML, Shea TC, Alexander MD. Davis JM, et al. Among authors: ivanova a. Biol Blood Marrow Transplant. 2019 Feb;25(2):391-397. doi: 10.1016/j.bbmt.2018.09.017. Epub 2018 Sep 19. Biol Blood Marrow Transplant. 2019. PMID: 30244102 Free article.
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
Ramos CA, Grover NS, Beaven AW, Lulla PD, Wu MF, Ivanova A, Wang T, Shea TC, Rooney CM, Dittus C, Park SI, Gee AP, Eldridge PW, McKay KL, Mehta B, Cheng CJ, Buchanan FB, Grilley BJ, Morrison K, Brenner MK, Serody JS, Dotti G, Heslop HE, Savoldo B. Ramos CA, et al. Among authors: ivanova a. J Clin Oncol. 2020 Nov 10;38(32):3794-3804. doi: 10.1200/JCO.20.01342. Epub 2020 Jul 23. J Clin Oncol. 2020. PMID: 32701411 Free PMC article. Clinical Trial.
Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung Cancer.
Weiss JM, Villaruz LC, O'Brien J, Ivanova A, Lee C, Olson JG, Pollack G, Gorman R, Socinski MA, Stinchombe TE. Weiss JM, et al. Among authors: ivanova a. Clin Lung Cancer. 2016 Mar;17(2):128-32. doi: 10.1016/j.cllc.2015.12.006. Epub 2015 Dec 17. Clin Lung Cancer. 2016. PMID: 26774201 Free PMC article. Clinical Trial.
Antimicrobial Resistance and Urinary Tract Infection Recurrence.
Nelson CP, Hoberman A, Shaikh N, Keren R, Mathews R, Greenfield SP, Mattoo TK, Gotman N, Ivanova A, Moxey-Mims M, Carpenter MA, Chesney RW. Nelson CP, et al. Among authors: ivanova a. Pediatrics. 2016 Apr;137(4):e20152490. doi: 10.1542/peds.2015-2490. Epub 2016 Mar 11. Pediatrics. 2016. PMID: 26969273 Free PMC article.
Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure.
Bostom A, Steubl D, Garimella PS, Franceschini N, Roberts MB, Pasch A, Ix JH, Tuttle KR, Ivanova A, Shireman T, Kim SJ, Gohh R, Weiner DE, Levey AS, Hsu CY, Kusek JW, Eaton CB. Bostom A, et al. Among authors: ivanova a. Am J Nephrol. 2018;47(4):275-282. doi: 10.1159/000489095. Epub 2018 Apr 26. Am J Nephrol. 2018. PMID: 29698955 Free PMC article. Clinical Trial.
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study.
Grover NS, Hucks G, Riches ML, Ivanova A, Moore DT, Shea TC, Seegars MB, Armistead PM, Kasow KA, Beaven AW, Dittus C, Coghill JM, Jamieson KJ, Vincent BG, Wood WA, Cheng C, Morrison JK, West J, Cavallo T, Dotti G, Serody JS, Savoldo B. Grover NS, et al. Among authors: ivanova a. Lancet Haematol. 2024 May;11(5):e358-e367. doi: 10.1016/S2352-3026(24)00064-4. Epub 2024 Mar 28. Lancet Haematol. 2024. PMID: 38555923 Clinical Trial.
1,253 results